-
EP3156419
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3156419
| EP3156419 - ANTIBODIES AGAINST CSF-1R [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.04.2019 Database last updated on 12.07.2024 | |
| Former | Examination is in progress Status updated on 01.06.2018 | ||
| Former | Request for examination was made Status updated on 27.10.2017 | ||
| Former | The application has been published Status updated on 20.03.2017 | Most recent event Tooltip | 26.04.2019 | Application deemed to be withdrawn | published on 29.05.2019 [2019/22] | Applicant(s) | For all designated states ImClone LLC 440 Route 22 East Bridgewater, NJ 08807 / US | [2017/16] | Inventor(s) | 01 /
DOODY, Jacqueline Francoise c/o Eli Lilly and Company Lilly Corporate Center Indianapolis, Indiana 46285 / US | 02 /
LI Yanxia c/o Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 / US | [2017/16] | Representative(s) | O'Connor, David Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | [N/P] |
| Former [2017/16] | O'Connor, David Eli Lilly and Company Limited Lilly Research Centre Erl Wood Manor Sunninghill Road Windlesham, Surrey GU20 6PH / GB | Application number, filing date | 16196811.0 | 28.03.2011 | [2017/16] | Priority number, date | US20100319896P | 01.04.2010 Original published format: US 319896 P | [2017/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3156419 | Date: | 19.04.2017 | Language: | EN | [2017/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 31.01.2017 | Classification | IPC: | C07K16/28, A61K39/395, C07K16/32, A61P35/02, A61P35/00, A61K45/06, A61K39/00 | [2017/16] | CPC: |
C07K16/2866 (EP,US);
C07K16/28 (KR);
A61K39/395 (KR);
A61K39/39541 (EP,US);
A61K39/39558 (EP,US);
A61K45/06 (EP,US);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
C07K16/32 (EP,US);
A61K2039/505 (EP,US);
A61K2039/507 (EP,US);
C07K2317/24 (EP,US);
C07K2317/33 (EP,US);
C07K2317/565 (EP,US);
C07K2317/73 (EP,US);
C07K2317/732 (EP,US);
C07K2317/76 (EP,US);
| C-Set: |
A61K39/39541, A61K2300/00 (EP,US);
A61K39/39558, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/48] |
| Former [2017/16] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 19.10.2017 | ME | 19.10.2017 | Title | German: | ANTIKÖRPER GEGEN CSF-1R | [2017/16] | English: | ANTIBODIES AGAINST CSF-1R | [2017/16] | French: | ANTICORPS ANTI-CSF-1R | [2017/16] | Examination procedure | 02.11.2016 | Date on which the examining division has become responsible | 19.10.2017 | Examination requested [2017/48] | 24.11.2017 | Amendment by applicant (claims and/or description) | 01.06.2018 | Despatch of a communication from the examining division (Time limit: M06) | 12.12.2018 | Application deemed to be withdrawn, date of legal effect [2019/22] | 15.01.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/22] | Parent application(s) Tooltip | EP11713416.3 / EP2552966 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 24.11.2017 | Request for further processing filed | 24.11.2017 | Full payment received (date of receipt of payment) Request granted | 11.12.2017 | Decision despatched | Fees paid | Renewal fee | 02.03.2017 | Renewal fee patent year 03 | 02.03.2017 | Renewal fee patent year 04 | 02.03.2017 | Renewal fee patent year 05 | 02.03.2017 | Renewal fee patent year 06 | 31.03.2017 | Renewal fee patent year 07 | 03.04.2018 | Renewal fee patent year 08 | 01.04.2019 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2009026303 (AMGEN INC [US], et al) [Y] 1-24 * the whole document *; | [A]WO2009112245 (TRANSGENE SA [FR], et al) [A] 1-24 * the whole document *; | [Y] - RESLAN LINA ET AL, "Understanding and circumventing resistance to anticancer monoclonal antibodies.", MABS 2009 MAY-JUN LNKD- PUBMED:20065642, (200905), vol. 1, no. 3, ISSN 1942-0870, pages 222 - 229, XP002638422 [Y] 1-24 * the whole document * | [A] - LIN HAISHAN ET AL, "Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.", SCIENCE (NEW YORK, N.Y.) 9 MAY 2008 LNKD- PUBMED:18467591, (20080509), vol. 320, no. 5877, ISSN 1095-9203, pages 807 - 811, XP002638423 [A] 1-24 * the whole document * DOI: http://dx.doi.org/10.1126/SCIENCE.1154370 | by applicant | EP0239400 | EP0332424 | WO8909622 | EP0338745 | WO2009026303 | - KABAT ET AL., ANN. NY ACAD. SCI., (1971), vol. 190, pages 382 - 93 | - YANG ET AL., J. MOL. BIOL., (1995), vol. 254, pages 392 - 403 | - HAWKINS ET AL., J. MOL. BIOL., (1992), vol. 226, pages 889 - 96 | - LOW ET AL., J. MOL. BIOL., (1996), vol. 250, pages 359 - 68 | - KOHLER; MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497 | - BURDON ET AL., Laboratory Techniques in Biochemistry and Molecular Biology, ELSEVIER SCIENCE PUBLISHERS, vol. 13 | - HUSE ET AL., SCIENCE, (1989), vol. 246, pages 1275 - 1281 | - LAMOYI ET AL., J. IMMUNOL. METHODS, (1983), vol. 56, pages 235 - 243 | - PARHAM, J. IMMUNOL., (1983), vol. 131, pages 2895 - 2902 | - P.J. SOUTHERN; P. BERG, J. MOL. APPL. GENET., (1982), vol. 1, pages 327 - 41 | - SUBRAMANI ET AL., MOL. CELL. BIOL., (1981), vol. 1, pages 854 - 64 | - KAUFMANN; SHARP, J. MOL. BIOL., (1982), vol. 159, pages 601 - 21 | - SCAHILL ET AL., PROC. NAT'L ACAD. SCI. USA, (1983), vol. 80, pages 4654 - 59 | - URLAUB; CHASIN, PROC. NAT'L ACAD. SCI. USA, (1980), vol. 77, pages 4216 - 20 | - LAWICKI ET AL., CLIN. CHIM. ACTA, (2006), vol. 317, pages 112 - 116 | - MROCZHO ET AL., CLIN. CHIM. ACTA, (2007), vol. 380, pages 208 - 212 | - WANG ET AL., MOL. CELL. BIOL, (1993), vol. 13, page 5348 | - SOARES ET AL., MODERN PATHOL., (2009), vol. 22, pages 744 - 752 | - STEIDL ET AL., NEW ENGL. J. MED, (2010), vol. 362, pages 875 - 885 | - ZHENG ET AL., BLOOD, (2009), vol. 114, pages 3625 - 3628 | - AHARINEJAD ET AL., CANCER RES., (2002), vol. 62, pages 5317 - 5324 | - TOY ET AL., GYN. ONCOL., (2001), vol. 80, pages 194 - 200 | - ZHANG ET AL., GYN. ONCOL., (2007), vol. 107, pages 526 - 531 | - ZHU ET AL., J. CLIN. ONCOL., (2008), vol. 26, pages 2707 - 2716 | - GERHARZ ET AL., UROL., (2001), vol. 58, pages 821 - 827 | - LIN ET AL., SCIENCE, (2008), vol. 320, pages 807 - 11 |